ciprofloxacin has been researched along with Corneal Ulcer in 76 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Corneal Ulcer: Loss of epithelial tissue from the surface of the cornea due to progressive erosion and necrosis of the tissue; usually caused by bacterial, fungal, or viral infection.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Knowledge on possible delaying effects of topical ciprofloxacin on corneal ulcer healing is scarce in avian patients." | 9.69 | Evaluation of delaying effects of different short-term dosage regimens of topical ciprofloxacin on corneal ulcer healing in an avian model. ( Masoudian, M; Mosleh, N; Namazi, F; Shomali, T; Tavangarrad, N, 2023) |
| "This prospective, randomized, double-masked controlled clinical trial was conducted on 41 patients (41 eyes) with suspected bacterial corneal ulcers who were randomized into 2 groups: 23 patients were in the lomefloxacin group and 18 patients in the ciprofloxacin group." | 9.11 | Comparison of topical lomefloxacin 0.3 per cent versus topical ciprofloxacin 0.3 per cent for the treatment of presumed bacterial corneal ulcers. ( Booranapong, W; Kosrirukvongs, P; Prabhasawat, P; Srivannaboon, S; Suttiprakarn, P, 2004) |
| "To assess topical ciprofloxacin in patients with moderate severity of suspected bacterial corneal ulcers." | 9.09 | Topical ciprofloxacin for bacterial corneal ulcer. ( Buranapongs, W; Kosrirukvongs, P, 2000) |
| "3% monotherapy is equivalent clinically and statistically to standard therapy (fortified tobramycin-cefazolin) for the treatment of bacterial corneal ulcers and produces significantly less discomfort." | 9.08 | Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers. Ciprofloxacin Bacterial Keratitis Study Group. ( Adenis, JP; Badrinath, SS; Caldwell, DR; Eiferman, RA; Hyndiuk, RA; Katz, HR; Klauss, V; Reddy, MK; Rosenwasser, GO; Santos, CI, 1996) |
| "3% is at least as effective as ciprofloxacin at healing corneal ulcers infected with Pseudomonas aeruginosa when gatifloxacin is administered less frequently than ciprofloxacin." | 7.73 | Comparison of ophthalmic gatifloxacin 0.3% and ciprofloxacin 0.3% in healing of corneal ulcers associated with Pseudomonas aeruginosa-induced ulcerative keratitis in rabbits. ( Carrier, M; Jensen, H; Short, B; Zerouala, C, 2005) |
| "Knowledge on possible delaying effects of topical ciprofloxacin on corneal ulcer healing is scarce in avian patients." | 5.69 | Evaluation of delaying effects of different short-term dosage regimens of topical ciprofloxacin on corneal ulcer healing in an avian model. ( Masoudian, M; Mosleh, N; Namazi, F; Shomali, T; Tavangarrad, N, 2023) |
| "Honey based ophthalmic drop can acceleratethe corneal epithelial defect healing in patients with foreign body induced corneal ulcer, compared to ophthalmic ciprofloxacin as a standard treatment." | 5.41 | Efficacy of Honey-based Ophthalmic Formulation in Patients with Corneal Ulcer: A Randomized Clinical Trial. ( Akbarizadeh, AR; Daneshamouz, S; Heydari, M; Nejabat, M; Soltanzadeh, K; Yasemi, M, 2021) |
| "Lomefloxacin was found to have significant efficacy in the healing of Staphylococcus aureus-induced corneal ulcers and associated lesions." | 5.30 | Comparative studies on topical lomefloxacin and ciprofloxacin on ocular kinetic and experimental corneal ulcer. ( Agarwal, HC; Biswas, NR; Gupta, SK; Gupta, YK; Velpandian, T, 1999) |
| "This prospective, randomized, double-masked controlled clinical trial was conducted on 41 patients (41 eyes) with suspected bacterial corneal ulcers who were randomized into 2 groups: 23 patients were in the lomefloxacin group and 18 patients in the ciprofloxacin group." | 5.11 | Comparison of topical lomefloxacin 0.3 per cent versus topical ciprofloxacin 0.3 per cent for the treatment of presumed bacterial corneal ulcers. ( Booranapong, W; Kosrirukvongs, P; Prabhasawat, P; Srivannaboon, S; Suttiprakarn, P, 2004) |
| "To assess topical ciprofloxacin in patients with moderate severity of suspected bacterial corneal ulcers." | 5.09 | Topical ciprofloxacin for bacterial corneal ulcer. ( Buranapongs, W; Kosrirukvongs, P, 2000) |
| "3% monotherapy is equivalent clinically and statistically to standard therapy (fortified tobramycin-cefazolin) for the treatment of bacterial corneal ulcers and produces significantly less discomfort." | 5.08 | Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers. Ciprofloxacin Bacterial Keratitis Study Group. ( Adenis, JP; Badrinath, SS; Caldwell, DR; Eiferman, RA; Hyndiuk, RA; Katz, HR; Klauss, V; Reddy, MK; Rosenwasser, GO; Santos, CI, 1996) |
| "To compare the therapeutic effectiveness of a single intrastromal dose of gentamycin, tobramycin, ciprofloxacin and ofloxacin for the treatment of corneal ulcers due to Pseudomonas aeruginosa." | 3.75 | [Bacterial corneal ulcer treated with intrastromal antibiotic. Experimental model in vivo]. ( Naranjo-Tackman, R; Stangogiannis-Druya, C; Stangogiannis-Druya, E; Vanzzini, V; Villar-Kurí, J, 2009) |
| "3% is at least as effective as ciprofloxacin at healing corneal ulcers infected with Pseudomonas aeruginosa when gatifloxacin is administered less frequently than ciprofloxacin." | 3.73 | Comparison of ophthalmic gatifloxacin 0.3% and ciprofloxacin 0.3% in healing of corneal ulcers associated with Pseudomonas aeruginosa-induced ulcerative keratitis in rabbits. ( Carrier, M; Jensen, H; Short, B; Zerouala, C, 2005) |
| " Twelve days later, she was diagnosed with posterior scleritis and treated with oral ciprofloxacin." | 3.73 | Posterior scleritis secondary to Pseudomonas aeruginosa keratitis. ( Dastjerdi, M; Fahim, K; Houghton, O; Mian, SI, 2005) |
| "A patient underwent intensive topical treatment of an infectious corneal ulcer with commercially available ciprofloxacin 0." | 3.71 | Scanning electron microscopic study of a Ciloxan bottle blocked by ciprofloxacin crystals. ( John, T, 2001) |
| "To report a clinical case of a 21-year old male with a severe corneal abscess due to Pseudomonas aeruginosa refractory to intensive treatment with topical Ciprofloxacin." | 3.71 | [Pseudomonas aeruginosa corneal abscess refractory to fluoroquinolones]. ( Alós Cortés, JI; Arteaga Sánchez, A; Díaz Valle, D; Díaz-Valle, T; Poza Morales, Y; Toledano Fernández, N, 2002) |
| "Devices such as contact lenses and collagen shields have been used to improve the antibiotic bioavailability of eye drops formulations in the treatment of ulcerative keratitis." | 1.56 | PVA/anionic collagen membranes as drug carriers of ciprofloxacin hydrochloride with sustained antibacterial activity and potential use in the treatment of ulcerative keratitis. ( Chaud, MV; da Conceição Amaro Martins, V; Daza, JHU; Lopes Baratella da Cunha Camargo, I; Maria de Guzzi Plepis, A; Righetto, GM, 2020) |
| "Ciprofloxacin resistance was found in 8 (17." | 1.37 | Antibiotic resistance in microbial keratitis: ten-year experience of corneal scrapes in the United Kingdom. ( Baker, M; Gurbaxani, A; Nash, J; Shalchi, Z, 2011) |
| "Levofloxacin 1." | 1.36 | Topical levofloxacin 1.5% overcomes in vitro resistance in rabbit keratitis models. ( Gordon, YJ; Kowalski, RP; Mah, FS; Romanowski, EG; Shanks, RM, 2010) |
| "One month later, a recurrence of PUK on the donor button was noted." | 1.35 | Recurrence of peripheral ulcerative keratitis on the corneoscleral button in a young man treated successfully with oral corticosteroids. ( Bakiah, S; Ibrahim, M; Selvaraja, V; Wahid, WA, 2008) |
| "An 11-year-old boy, a known case of lamellar ichthyosis, presented with microbial keratitis." | 1.35 | Microbial keratitis in a case of lamellar ichthyosis. ( Chaurasia, S; Das, S; Ramamurthy, B, 2008) |
| "Treatment with ciprofloxacin and amikacin resolved the ulcer." | 1.33 | Mycobacterium chelonae keratitis: elucidation of diagnosis through evaluation of smears of fluid from patient's contact lens care system. ( Bottone, EJ; Cho, KW, 2005) |
| "Fungal corneal ulcers are not uncommon." | 1.30 | Infectious keratitis in leprosy. ( Daniel, E; John, D, 1999) |
| "Ciprofloxacin was not detected by either method in the precipitate obtained from one patient." | 1.30 | Antibacterial activity of the white precipitate formed on the corneal surface after treatment with ciprofloxacin ophthalmic solution. ( Joseph, PR; Madhavan, HN; Rao, SK; Sulochana, KN, 1999) |
| "Lomefloxacin was found to have significant efficacy in the healing of Staphylococcus aureus-induced corneal ulcers and associated lesions." | 1.30 | Comparative studies on topical lomefloxacin and ciprofloxacin on ocular kinetic and experimental corneal ulcer. ( Agarwal, HC; Biswas, NR; Gupta, SK; Gupta, YK; Velpandian, T, 1999) |
| " These results suggest that either salt of prednisolone, when combined with ciprofloxacin, reduces ocular inflammation without affecting the antimicrobial efficacy of the antibiotic." | 1.29 | Prednisolone acetate or prednisolone phosphate concurrently administered with ciprofloxacin for the therapy of experimental Pseudomonas aeruginosa keratitis. ( Callegan, MC; Engel, LS; Hill, JM; Hobden, JA; O'Callaghan, RJ, 1993) |
| "Two patients had acquired immunodeficiency syndrome (AIDS), one was human immunodeficiency virus (HIV)-positive, and the fourth refused HIV testing." | 1.29 | Spontaneous ulcerative keratitis in immunocompromised patients. ( Aristimuño, B; Hemady, RK; Nirankari, VS; Rodrigues, MM, 1993) |
| "Ciprofloxacin appears to be an effective single agent in the treatment of ulcerative keratitis." | 1.29 | Comparison of topical ciprofloxacin to conventional antibiotic therapy in the treatment of ulcerative keratitis. ( Abrams, DA; Katz, HR; Parks, DJ; Sarfarazi, FA, 1993) |
| "Amikacin was more effective in reducing the number of organisms in corneas infected with ATCC-6841 than in corneas infected with the patient isolate (p = 0." | 1.28 | Mycobacterium fortuitum keratitis. A comparison of topical ciprofloxacin and amikacin in an animal model. ( Berlin, OG; Bruckner, DA; Holland, GN; Paschal, JF; Phinney, RB; Stevens, RK, 1992) |
| "Ciprofloxacin is a new quinolone antibiotic with a broad spectrum of activity against most aerobic gram-positive and gram-negative bacteria." | 1.28 | Successful treatment of methicillin-resistant Staphylococcus aureus Keratitis with topical ciprofloxacin. ( Fish, LA; Hill, JM; Hobden, JA; Insler, MS; O'Callaghan, RJ; Silbernagel, J, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 22 (28.95) | 18.2507 |
| 2000's | 35 (46.05) | 29.6817 |
| 2010's | 13 (17.11) | 24.3611 |
| 2020's | 6 (7.89) | 2.80 |
| Authors | Studies |
|---|---|
| Tavangarrad, N | 1 |
| Mosleh, N | 1 |
| Shomali, T | 1 |
| Namazi, F | 1 |
| Masoudian, M | 1 |
| Nejabat, M | 1 |
| Soltanzadeh, K | 1 |
| Yasemi, M | 1 |
| Daneshamouz, S | 1 |
| Akbarizadeh, AR | 1 |
| Heydari, M | 1 |
| Quan, AV | 1 |
| Huang, AM | 1 |
| Galor, A | 1 |
| Díaz Barrón, A | 1 |
| Sanz Gallen, L | 1 |
| Hervás Hernandis, JM | 1 |
| Tarragó Simón, E | 1 |
| Duch-Samper, AM | 1 |
| Cornée, C | 1 |
| Mainguy, A | 1 |
| Coeuru, D | 1 |
| Routier, M | 1 |
| Lebranchu, P | 1 |
| Vabres, B | 1 |
| Daza, JHU | 1 |
| Righetto, GM | 1 |
| Chaud, MV | 1 |
| da Conceição Amaro Martins, V | 1 |
| Lopes Baratella da Cunha Camargo, I | 1 |
| Maria de Guzzi Plepis, A | 1 |
| Palioura, S | 1 |
| Gibbons, A | 1 |
| Miller, D | 2 |
| OʼBrien, TP | 1 |
| Alfonso, EC | 2 |
| Spierer, O | 1 |
| Bennett, HY | 1 |
| Hayes, RA | 1 |
| O'Hagan, S | 1 |
| Fennelly, E | 1 |
| Greenan, E | 1 |
| Murphy, CC | 1 |
| Hazlett, LD | 1 |
| Ekanayaka, SA | 1 |
| McClellan, SA | 1 |
| Francis, R | 1 |
| Kaliamurthy, J | 3 |
| Kalavathy, CM | 4 |
| Parmar, P | 4 |
| Nelson Jesudasan, CA | 1 |
| Thomas, PA | 4 |
| Konda, N | 1 |
| Motukupally, SR | 1 |
| Garg, P | 2 |
| Sharma, S | 2 |
| Ali, MH | 1 |
| Willcox, MD | 1 |
| McDonald, EM | 1 |
| Ram, FS | 1 |
| Patel, DV | 1 |
| McGhee, CN | 1 |
| Sand, D | 1 |
| She, R | 1 |
| Shulman, IA | 1 |
| Chen, DS | 1 |
| Schur, M | 1 |
| Hsu, HY | 1 |
| Fernandes, M | 1 |
| Vira, D | 1 |
| Medikonda, R | 1 |
| Kumar, N | 1 |
| Wahid, WA | 1 |
| Selvaraja, V | 1 |
| Bakiah, S | 1 |
| Ibrahim, M | 1 |
| Karicherla, P | 1 |
| Hobden, JA | 4 |
| Stangogiannis-Druya, E | 1 |
| Stangogiannis-Druya, C | 1 |
| Naranjo-Tackman, R | 1 |
| Vanzzini, V | 1 |
| Villar-Kurí, J | 1 |
| Diec, J | 1 |
| Carnt, N | 2 |
| Tilia, D | 1 |
| Evans, V | 1 |
| Rao, V | 1 |
| Ozkan, J | 1 |
| Holden, BA | 2 |
| Kowalski, RP | 4 |
| Romanowski, EG | 3 |
| Mah, FS | 3 |
| Shanks, RM | 1 |
| Gordon, YJ | 4 |
| Shih, MH | 1 |
| Huang, FC | 1 |
| Borsali, E | 1 |
| Le Bouter, A | 1 |
| Abdiche, G | 1 |
| Goldschmdt, P | 1 |
| Legrand, P | 1 |
| Batellier, L | 1 |
| Gleize, D | 1 |
| Laroche, L | 1 |
| Chaumeil, C | 1 |
| Shalchi, Z | 1 |
| Gurbaxani, A | 1 |
| Baker, M | 1 |
| Nash, J | 1 |
| Salman, A | 2 |
| Jesudasan, CA | 3 |
| Donnenfeld, ED | 1 |
| O'Brien, TP | 3 |
| Solomon, R | 1 |
| Perry, HD | 1 |
| Speaker, MG | 1 |
| Wittpenn, J | 1 |
| Sweeney, DF | 1 |
| Sankaridurg, PR | 1 |
| Edwards, K | 1 |
| Stretton, S | 1 |
| Stapleton, F | 1 |
| Daines, BS | 1 |
| Vroman, DT | 1 |
| Sandoval, HP | 1 |
| Steed, LL | 1 |
| Solomon, KD | 1 |
| Wilhelmus, KR | 2 |
| Abshire, RL | 2 |
| Schlech, BA | 1 |
| Dhaliwal, DK | 1 |
| Karenchak, LM | 1 |
| Ritterband, DC | 1 |
| Lee, KY | 1 |
| Lim, L | 1 |
| Barequet, IS | 1 |
| Denton, P | 1 |
| Osterhout, GJ | 1 |
| Tuli, S | 1 |
| Booranapong, W | 1 |
| Kosrirukvongs, P | 2 |
| Prabhasawat, P | 1 |
| Srivannaboon, S | 1 |
| Suttiprakarn, P | 1 |
| Ramalingam, K | 1 |
| Hyon, JY | 1 |
| Joo, MJ | 1 |
| Hose, S | 1 |
| Sinha, D | 1 |
| Dick, JD | 1 |
| Weyenberg, W | 1 |
| Vermeire, A | 1 |
| Dhondt, MM | 1 |
| Adriaens, E | 1 |
| Kestelyn, P | 1 |
| Remon, JP | 1 |
| Ludwig, A | 1 |
| Jensen, H | 1 |
| Zerouala, C | 1 |
| Carrier, M | 1 |
| Short, B | 1 |
| Bottone, EJ | 1 |
| Cho, KW | 1 |
| Fahim, K | 1 |
| Houghton, O | 1 |
| Dastjerdi, M | 1 |
| Mian, SI | 1 |
| Caballero, AR | 1 |
| Marquart, ME | 1 |
| O'Callaghan, RJ | 4 |
| Thibodeaux, BA | 1 |
| Johnston, KH | 1 |
| Dajcs, JJ | 1 |
| Prasanth, DA | 1 |
| Schornack, MM | 1 |
| Peterson, D | 1 |
| Sharma, N | 1 |
| Sinha, R | 1 |
| Singhvi, A | 1 |
| Tandon, R | 1 |
| Yates, KA | 1 |
| Chaurasia, S | 1 |
| Das, S | 1 |
| Ramamurthy, B | 1 |
| Lee, SM | 1 |
| Kim, MK | 1 |
| Lee, JL | 1 |
| Wee, WR | 1 |
| Lee, JH | 1 |
| Guzek, JP | 1 |
| Chacko, D | 1 |
| Kettering, JD | 1 |
| Wessels, IF | 1 |
| Aprecio, RM | 1 |
| Engel, LS | 1 |
| Hill, JM | 3 |
| Callegan, MC | 2 |
| Hyndiuk, RA | 2 |
| Caldwell, DR | 2 |
| Folkens, AT | 1 |
| Godio, LB | 1 |
| Aristimuño, B | 1 |
| Nirankari, VS | 1 |
| Hemady, RK | 1 |
| Rodrigues, MM | 1 |
| Parks, DJ | 1 |
| Abrams, DA | 1 |
| Sarfarazi, FA | 1 |
| Katz, HR | 4 |
| Maffett, M | 1 |
| O'Day, DM | 1 |
| Leahey, AB | 1 |
| Jones, D | 1 |
| Eiferman, RA | 2 |
| Rosenwasser, GO | 1 |
| Santos, CI | 1 |
| Badrinath, SS | 1 |
| Reddy, MK | 1 |
| Adenis, JP | 1 |
| Klauss, V | 1 |
| Brancato, R | 1 |
| Carones, F | 1 |
| Venturi, E | 1 |
| Cavallero, A | 1 |
| Gesu, G | 1 |
| Hill, VE | 1 |
| Brownstein, S | 1 |
| Jackson, WB | 1 |
| Mintsioulis, G | 1 |
| Kunimoto, DY | 1 |
| Rao, GN | 1 |
| John, D | 1 |
| Daniel, E | 1 |
| Goldstein, MH | 1 |
| Colatrella, N | 1 |
| Daniel, TE | 1 |
| Madhavan, HN | 2 |
| Rao, SK | 2 |
| Joseph, PR | 1 |
| Sulochana, KN | 1 |
| Velpandian, T | 1 |
| Gupta, SK | 1 |
| Gupta, YK | 1 |
| Agarwal, HC | 1 |
| Biswas, NR | 1 |
| Alexandrakis, G | 1 |
| Buranapongs, W | 1 |
| Prajna, NV | 1 |
| George, C | 1 |
| Selvaraj, S | 1 |
| Lu, KL | 1 |
| McDonnell, PJ | 1 |
| Srinivasan, M | 1 |
| Chen, KH | 1 |
| Kuang, TM | 1 |
| Hsu, WM | 1 |
| Pinna, A | 1 |
| Sechi, LA | 1 |
| Zanetti, S | 1 |
| Usai, D | 1 |
| Delogu, G | 1 |
| Cappuccinelli, P | 1 |
| Carta, F | 1 |
| Snyder, JP | 1 |
| Nordquist, RE | 1 |
| John, T | 1 |
| Díaz Valle, D | 1 |
| Alós Cortés, JI | 1 |
| Arteaga Sánchez, A | 1 |
| Toledano Fernández, N | 1 |
| Poza Morales, Y | 1 |
| Díaz-Valle, T | 1 |
| Yolton, DP | 1 |
| Stevens, RK | 1 |
| Holland, GN | 1 |
| Paschal, JF | 1 |
| Phinney, RB | 1 |
| Berlin, OG | 1 |
| Bruckner, DA | 1 |
| Insler, MS | 2 |
| Snyder, ME | 1 |
| Fish, LA | 1 |
| Silbernagel, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Swiss PACK-CXL (Photoactivated Chromophore for Infectious Keratitis Cross-linking) Multicenter Trial for the Treatment of Infectious Keratitis[NCT02717871] | Phase 3 | 35 participants (Actual) | Interventional | 2016-03-31 | Completed | ||
| Contribution of Fast Molecular Bacterial Identification by Real-time PCR in Managing of Postoperative Acute Endophthalmitis[NCT02850653] | 150 participants (Anticipated) | Interventional | 2007-11-30 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 reviews available for ciprofloxacin and Corneal Ulcer
| Article | Year |
|---|---|
Topical antibiotics for the management of bacterial keratitis: an evidence-based review of high quality randomised controlled trials.
Topics: Administration, Topical; Anti-Bacterial Agents; Ciprofloxacin; Corneal Ulcer; Eye Infections, Bacter | 2014 |
Infectious keratitis after photorefractive keratectomy.
Topics: Adult; Ciprofloxacin; Corneal Ulcer; Cross Infection; Drug Therapy, Combination; Eye Infections, Bac | 2003 |
Microbial keratitis and vision loss with contact lenses.
Topics: Adult; Alcaligenes; Anti-Infective Agents; Ciprofloxacin; Contact Lenses, Extended-Wear; Corneal Ulc | 2003 |
Rapid diagnosis and treatment of mycobacterial keratitis after laser in situ keratomileusis.
Topics: Amikacin; Bacteriological Techniques; Ciprofloxacin; Clarithromycin; Corneal Ulcer; Diagnostic Techn | 2003 |
New antibacterial drugs for topical ophthalmic use.
Topics: Ciprofloxacin; Conjunctivitis, Bacterial; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, | 1992 |
10 trials available for ciprofloxacin and Corneal Ulcer
| Article | Year |
|---|---|
Evaluation of delaying effects of different short-term dosage regimens of topical ciprofloxacin on corneal ulcer healing in an avian model.
Topics: Animals; Ciprofloxacin; Cornea; Corneal Ulcer; Matrix Metalloproteinase 9; Ulcer | 2023 |
Efficacy of Honey-based Ophthalmic Formulation in Patients with Corneal Ulcer: A Randomized Clinical Trial.
Topics: Adult; Apitherapy; Ciprofloxacin; Corneal Ulcer; Eye Foreign Bodies; Female; Honey; Humans; Male; Mi | 2021 |
Influence of fluoroquinolone susceptibility on the therapeutic response of fluoroquinolone-treated bacterial keratitis.
Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Cornea; Corneal Ulcer; Drug Resistance, Bacterial; E | 2003 |
Comparison of topical lomefloxacin 0.3 per cent versus topical ciprofloxacin 0.3 per cent for the treatment of presumed bacterial corneal ulcers.
Topics: Administration, Topical; Adolescent; Adult; Anti-Infective Agents; Chi-Square Distribution; Child; C | 2004 |
Ocular bioerodible minitablets as strategy for the management of microbial keratitis.
Topics: Absorbable Implants; Administration, Topical; Adult; Anti-Infective Agents; Chromatography, High Pre | 2004 |
Comparison of topical gatifloxacin 0.3% and ciprofloxacin 0.3% for the treatment of bacterial keratitis.
Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Bacteria; Child; Ciprofloxacin; | 2006 |
0.3% ciprofloxacin ophthalmic ointment in the treatment of bacterial keratitis. The Ciprofloxacin Ointment/Bacterial Keratitis Study Group.
Topics: Administration, Topical; Bacteria; Ciprofloxacin; Cornea; Corneal Ulcer; Drug Administration Schedul | 1993 |
Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers. Ciprofloxacin Bacterial Keratitis Study Group.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; | 1996 |
Topical ciprofloxacin for bacterial corneal ulcer.
Topics: Administration, Topical; Adolescent; Adult; Aged; Anti-Infective Agents; Bacterial Infections; Cipro | 2000 |
Bacteriologic and clinical efficacy of ofloxacin 0.3% versus ciprofloxacin 0.3% ophthalmic solutions in the treatment of patients with culture-positive bacterial keratitis.
Topics: Adult; Anti-Infective Agents; Bacteria; Ciprofloxacin; Corneal Ulcer; Double-Blind Method; Drug Admi | 2001 |
61 other studies available for ciprofloxacin and Corneal Ulcer
| Article | Year |
|---|---|
Ciprofloxacin Corneal Deposits With Complete Dissipation After Switching to Moxifloxacin.
Topics: Administration, Ophthalmic; Aged; Anti-Bacterial Agents; Chemical Precipitation; Ciprofloxacin; Corn | 2020 |
Bacterial keratitis due to Moraxella nonliquefaciens.
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ceftazidime; Ciprofloxac | 2020 |
[Corneal ulcer secondary to Pasteurella multocida and Klebsiella oxytoca in a 79-year-old patient with dysthyroid orbitopathy].
Topics: Aged; Amnion; Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Coinfection; Combined Modality Ther | 2020 |
PVA/anionic collagen membranes as drug carriers of ciprofloxacin hydrochloride with sustained antibacterial activity and potential use in the treatment of ulcerative keratitis.
Topics: Anti-Bacterial Agents; Biocompatible Materials; Ciprofloxacin; Collagen; Contact Lenses; Cornea; Cor | 2020 |
Clinical Features, Antibiotic Susceptibility Profile, and Outcomes of Infectious Keratitis Caused by Stenotrophomonas maltophilia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Corneal | 2018 |
First two cases of Exserohilum rostratum keratitis in Australia.
Topics: Adult; Antifungal Agents; Ascomycota; Australia; Ciprofloxacin; Corneal Ulcer; Drug Therapy, Combina | 2019 |
Corneal melt secondary to eosinophilic granulomatosis with polyangiitis.
Topics: Aged; Anti-Bacterial Agents; Antibodies, Antineutrophil Cytoplasmic; Ciprofloxacin; Corneal Perforat | 2019 |
Glycyrrhizin Use for Multi-Drug Resistant Pseudomonas aeruginosa: In Vitro and In Vivo Studies.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Ciprofloxacin; Corneal Ulcer; Drug Resista | 2019 |
Spectrum of bacterial keratitis at a tertiary eye care centre in India.
Topics: Aza Compounds; Ciprofloxacin; Corneal Ulcer; Fluoroquinolones; Gatifloxacin; Gram-Positive Bacteria; | 2013 |
Microbial analyses of contact lens-associated microbial keratitis.
Topics: Adult; Anti-Bacterial Agents; Bacteria; Cefazolin; Ciprofloxacin; Contact Lenses; Corneal Ulcer; Dru | 2014 |
Microbial keratitis in los angeles: the doheny eye institute and the los angeles county hospital experience.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Child; Ciprofloxacin; C | 2015 |
Extensively and pan-drug resistant Pseudomonas aeruginosa keratitis: clinical features, risk factors, and outcome.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Colistin; Corneal Ulcer; Drug Resistance, Multiple, Bacterial; | 2016 |
Recurrence of peripheral ulcerative keratitis on the corneoscleral button in a young man treated successfully with oral corticosteroids.
Topics: Administration, Oral; Adult; Amnion; Anti-Infective Agents; Ciprofloxacin; Corneal Transplantation; | 2008 |
Nona-D-arginine therapy for Pseudomonas aeruginosa keratitis.
Topics: Animals; Ciprofloxacin; Colony Count, Microbial; Cornea; Corneal Ulcer; Disease Models, Animal; Drug | 2009 |
[Bacterial corneal ulcer treated with intrastromal antibiotic. Experimental model in vivo].
Topics: Analysis of Variance; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Cornea; | 2009 |
Prompt diagnosis and treatment of microbial keratitis in a daily wear lens.
Topics: Administration, Topical; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Contact Lenses; | 2009 |
Topical levofloxacin 1.5% overcomes in vitro resistance in rabbit keratitis models.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Cefazolin; Ciprofloxacin; Colony Count, Mic | 2010 |
Effects of photodynamic therapy on rapidly growing nontuberculous mycobacteria keratitis.
Topics: Amikacin; Animals; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Colony Count, Microbial; Cor | 2011 |
[Ornithinimicrobium pekingense ocular infection].
Topics: Actinomycetales; Actinomycetales Infections; Aged; Cataract; Ciprofloxacin; Corneal Edema; Corneal U | 2011 |
Antibiotic resistance in microbial keratitis: ten-year experience of corneal scrapes in the United Kingdom.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Bacteriological Techniques; Cefurox | 2011 |
Pneumococcal keratitis: a clinical profile.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Cornea; Corneal Ulcer; Dacryocystitis; Dacryocystorhino | 2003 |
Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates.
Topics: Anti-Infective Agents; Aza Compounds; Bacteria; Ciprofloxacin; Corneal Ulcer; Drug Resistance, Bacte | 2003 |
Pseudomonas keratitis associated with continuous wear silicone-hydrogel soft contact lens: a case report.
Topics: Adult; Cefazolin; Ciprofloxacin; Contact Lenses, Extended-Wear; Corneal Ulcer; Drug Therapy, Combina | 2003 |
Treatment of experimental bacterial keratitis with topical trovafloxacin.
Topics: Administration, Topical; Animals; Anti-Infective Agents; Biological Availability; Ciprofloxacin; Col | 2004 |
Trimethoprim-sulphamethoxazole therapy in Nocardia keratitis.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Child; Ciprofloxacin; Corneal Ulcer; Eye Infections, | 2004 |
Comparative efficacy of topical gatifloxacin with ciprofloxacin, amikacin, and clarithromycin in the treatment of experimental Mycobacterium chelonae keratitis.
Topics: Administration, Topical; Amikacin; Animals; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Co | 2004 |
Comparison of ophthalmic gatifloxacin 0.3% and ciprofloxacin 0.3% in healing of corneal ulcers associated with Pseudomonas aeruginosa-induced ulcerative keratitis in rabbits.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Colony Count, Microbial; Cornea; Corneal Ulcer; Disea | 2005 |
Mycobacterium chelonae keratitis: elucidation of diagnosis through evaluation of smears of fluid from patient's contact lens care system.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Contact Lens Solutions; Contact Lenses; Corne | 2005 |
Posterior scleritis secondary to Pseudomonas aeruginosa keratitis.
Topics: Anti-Infective Agents; Ciprofloxacin; Corneal Ulcer; Disease Progression; Eye Enucleation; Eye Infec | 2005 |
Effectiveness of fluoroquinolones against Mycobacterium abscessus in vivo.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Aza Compounds; Ciprofloxacin; Colony Count, | 2006 |
Staphylococcus aureus ulcer associated with continuous wear of silicone hydrogel contact lenses.
Topics: Adult; Anti-Bacterial Agents; Cefazolin; Ciprofloxacin; Contact Lenses, Extended-Wear; Corneal Ulcer | 2006 |
Pseudomonas keratitis after laser in situ keratomileusis.
Topics: Adult; Anti-Bacterial Agents; Cefazolin; Cephalosporin Resistance; Ciprofloxacin; Corneal Ulcer; Dru | 2006 |
Zymar (Gatifloxacin 0.3%) shows excellent Gram-negative activity against Serratia marcescens and Pseudomonas aeruginosa in a New Zealand White rabbit keratitis model.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Colony Count, Microbial; Corneal Ulcer; Disease Model | 2007 |
Microbial keratitis in a case of lamellar ichthyosis.
Topics: Anti-Bacterial Agents; Cefazolin; Child; Ciprofloxacin; Corneal Ulcer; Drug Therapy, Combination; Ec | 2008 |
Experience of Comamonas acidovorans keratitis with delayed onset and treatment response in immunocompromised cornea.
Topics: Amikacin; Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Corneal Ulcer; Delftia acidovorans; Dru | 2008 |
Comparison of topical ciprofloxacin to conventional antibiotic therapy in the treatment of experimental Pseudomonas aeruginosa keratitis.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Ciprofloxacin; Cornea; Corneal Ulcer; Disea | 1994 |
Prednisolone acetate or prednisolone phosphate concurrently administered with ciprofloxacin for the therapy of experimental Pseudomonas aeruginosa keratitis.
Topics: Animals; Aqueous Humor; Ciprofloxacin; Corneal Ulcer; Disease Models, Animal; Drug Therapy, Combinat | 1993 |
Spontaneous ulcerative keratitis in immunocompromised patients.
Topics: Acquired Immunodeficiency Syndrome; Administration, Topical; Adult; Amikacin; Amphotericin B; Candid | 1993 |
Comparison of topical ciprofloxacin to conventional antibiotic therapy in the treatment of ulcerative keratitis.
Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Cefazolin; Ciprofloxacin; Corneal Ulcer; Drug | 1993 |
Ciprofloxacin-resistant bacterial keratitis.
Topics: Aged; Ciprofloxacin; Cornea; Corneal Ulcer; Drug Resistance, Microbial; Eye Infections, Bacterial; H | 1993 |
Haemophilus influenzae central corneal ulcer associated with cosmetic lens wear.
Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; Contact Lenses; Cornea; Corneal Ulcer; Drug Therapy, Co | 1996 |
Mycobacterium chelonae keratitis after excimer laser photorefractive keratectomy.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Cornea; Corneal Ulcer; Eye In | 1997 |
Infectious keratopathy complicating photorefractive keratectomy.
Topics: Adult; Cefazolin; Ciprofloxacin; Cornea; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, B | 1998 |
In vitro susceptibility of bacterial keratitis pathogens to ciprofloxacin. Emerging resistance.
Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Colony Count, Microbial; Corneal Ulcer; Drug Resista | 1999 |
Infectious keratitis in leprosy.
Topics: Adult; Aged; Anti-Infective Agents; Ciprofloxacin; Corneal Ulcer; Female; Humans; Ketoconazole; Lepr | 1999 |
Emerging fluoroquinolone resistance in bacterial keratitis: a 5-year review.
Topics: Anti-Infective Agents; Ciprofloxacin; Corneal Ulcer; Drug Resistance, Microbial; Eye Infections, Bac | 1999 |
Emerging fluoroquinolone resistance in bacterial keratitis: a 5-year review.
Topics: Anti-Infective Agents; Ciprofloxacin; Corneal Ulcer; Drug Resistance, Microbial; Eye Infections, Bac | 1999 |
Emerging fluoroquinolone resistance in bacterial keratitis: a 5-year review.
Topics: Anti-Infective Agents; Ciprofloxacin; Corneal Ulcer; Drug Resistance, Microbial; Eye Infections, Bac | 1999 |
Emerging fluoroquinolone resistance in bacterial keratitis: a 5-year review.
Topics: Anti-Infective Agents; Ciprofloxacin; Corneal Ulcer; Drug Resistance, Microbial; Eye Infections, Bac | 1999 |
Crack eye syndrome.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Cocaine-Related Disorders; Corneal Ulcer; Crack Cocaine | 1999 |
Antibacterial activity of the white precipitate formed on the corneal surface after treatment with ciprofloxacin ophthalmic solution.
Topics: Adult; Anti-Infective Agents; Chemical Precipitation; Child; Child, Preschool; Chromatography, High | 1999 |
Ciprofloxacin monotherapy and bacterial keratitis.
Topics: Anti-Infective Agents; Ciprofloxacin; Corneal Ulcer; Corynebacterium; Drug Resistance, Microbial; Ey | 1999 |
Comparative studies on topical lomefloxacin and ciprofloxacin on ocular kinetic and experimental corneal ulcer.
Topics: Administration, Topical; Animals; Anti-Infective Agents; Biological Availability; Chromatography, Hi | 1999 |
Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Ciprofloxacin; Cornea; Corneal Ulcer; Drug R | 2000 |
Serratia Marcescens corneal ulcer as a complication of orthokeratology.
Topics: Anti-Infective Agents; Astigmatism; Child; Ciprofloxacin; Contact Lenses; Cornea; Corneal Ulcer; Eye | 2001 |
Bacillus cereus keratitis associated with contact lens wear.
Topics: Bacillaceae Infections; Bacillus cereus; Ciprofloxacin; Conjunctiva; Contact Lens Solutions; Contact | 2001 |
Ciprofloxacin microprecipitates and macroprecipitates in the human corneal epithelium.
Topics: Aged; Anti-Infective Agents; Antibiotic Prophylaxis; Chemical Precipitation; Chromatography, High Pr | 2001 |
Scanning electron microscopic study of a Ciloxan bottle blocked by ciprofloxacin crystals.
Topics: Anti-Infective Agents; Ciprofloxacin; Corneal Ulcer; Crystallization; Humans; Instillation, Drug; Mi | 2001 |
Ciprofloxacin precipitates in the corneal epithelium.
Topics: Anti-Infective Agents; Chemical Precipitation; Ciprofloxacin; Corneal Ulcer; Epithelium, Corneal; Hu | 2002 |
[Pseudomonas aeruginosa corneal abscess refractory to fluoroquinolones].
Topics: Abscess; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Ceftazidime; Ciprofloxacin; Contact Le | 2002 |
Mycobacterium fortuitum keratitis. A comparison of topical ciprofloxacin and amikacin in an animal model.
Topics: Amikacin; Animals; Ciprofloxacin; Corneal Ulcer; Disease Models, Animal; Eye Infections, Bacterial; | 1992 |
Methicillin-resistant Staphylococcus aureus keratitis in the rabbit: therapy with ciprofloxacin, vancomycin and cefazolin.
Topics: Animals; Cefazolin; Ciprofloxacin; Corneal Ulcer; Disease Models, Animal; Drug Therapy, Combination; | 1992 |
Ciprofloxacin-resistant bacterial keratitis.
Topics: Aged; Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Corneal Ulcer; Drug Resistance, Microbial; Eye | 1992 |
Successful treatment of methicillin-resistant Staphylococcus aureus Keratitis with topical ciprofloxacin.
Topics: Administration, Topical; Aged; Aged, 80 and over; Ciprofloxacin; Corneal Ulcer; Eye Infections, Bact | 1991 |